SG10201808645TA - Fortified Micronutrient Salt Formulations - Google Patents

Fortified Micronutrient Salt Formulations

Info

Publication number
SG10201808645TA
SG10201808645TA SG10201808645TA SG10201808645TA SG10201808645TA SG 10201808645T A SG10201808645T A SG 10201808645TA SG 10201808645T A SG10201808645T A SG 10201808645TA SG 10201808645T A SG10201808645T A SG 10201808645TA SG 10201808645T A SG10201808645T A SG 10201808645TA
Authority
SG
Singapore
Prior art keywords
micronutrients
salt
sensitive
formulations
stomach
Prior art date
Application number
SG10201808645TA
Inventor
Ana Jaklenec
Xian Xu
Lowell Wood
Andrew Welkhoff Philip
William Gates
Boris Nikolic
Robert Langer
Original Assignee
Massachusetts Inst Technology
Tokitae Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Inst Technology, Tokitae Llc filed Critical Massachusetts Inst Technology
Publication of SG10201808645TA publication Critical patent/SG10201808645TA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
    • A23L27/72—Encapsulation
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
    • A23L27/74—Fixation, conservation, or encapsulation of flavouring agents with a synthetic polymer matrix or excipient, e.g. vinylic, acrylic polymers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

FORTIFIED MICRONUTRIENT SALT FORMULATIONS Salt formulations, which are resistant to moisture and cooking conditions, are described herein. The formulations provide particles of micronutrients and vitamins encapsulated within heat resistant pH-sensitive water-insoluble polymers, which are packaged 5 within a salt shell. The pH-sensitive, water-insoluble, thermally stable materials stabilize the micronutrients, particularly at high temperatures, such as during food preparation and cooking, and release the micronutrients at the desired locations such as the stomach, small intestine, etc. Preferred pH-sensitive polymers release at a low pH, less than the pH present in the stomach. The particles can be used to deliver daily-recommended doses of micronutrients 10 simultaneously with salt, eliminating the need for vitamin pills. This is particularly important in populations suffering from severe malnutrition. Figure 1
SG10201808645TA 2013-12-16 2014-12-16 Fortified Micronutrient Salt Formulations SG10201808645TA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361916485P 2013-12-16 2013-12-16
US201462036405P 2014-08-12 2014-08-12
US201462066551P 2014-10-21 2014-10-21

Publications (1)

Publication Number Publication Date
SG10201808645TA true SG10201808645TA (en) 2018-11-29

Family

ID=52293246

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201604805XA SG11201604805XA (en) 2013-12-16 2014-12-16 Fortified micronutrient salt formulations
SG10201808645TA SG10201808645TA (en) 2013-12-16 2014-12-16 Fortified Micronutrient Salt Formulations

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG11201604805XA SG11201604805XA (en) 2013-12-16 2014-12-16 Fortified micronutrient salt formulations

Country Status (7)

Country Link
US (3) US9649279B2 (en)
EP (1) EP3082471B1 (en)
CN (1) CN106061292B (en)
ES (1) ES2647791T3 (en)
MX (1) MX2016007786A (en)
SG (2) SG11201604805XA (en)
WO (1) WO2015095185A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2016007786A (en) * 2013-12-16 2017-03-03 Massachusetts Inst Technology Fortified micronutrient salt formulations.
FR3042387B1 (en) * 2015-10-20 2019-05-24 Ynsect PRESERVATION OF WATER-SOLUBLE VITAMINS
WO2017075096A1 (en) * 2015-10-26 2017-05-04 Blaesi Aron H Solid dosage form immediate drug release and apparatus and method for manufacture thereof
US11129798B2 (en) 2016-08-19 2021-09-28 Aron H. Blaesi Fibrous dosage form
ES2706101A1 (en) * 2017-09-26 2019-03-27 Liofilizados Girona S L Method for obtaining microcapsules, microcapsules obtained by the same, and nutraceutical or pharmaceutical compositions comprising said microcapsules (Machine-translation by Google Translate, not legally binding)
CN107712909A (en) * 2017-11-13 2018-02-23 济川药业集团有限公司 A kind of iron zinc Muti-vitamine Oral Solution
CN111801024A (en) * 2018-01-04 2020-10-20 麻省理工学院 Water-soluble and fat-soluble micronutrient-stabilized particles with enteric polymer barrier
EP3771312A4 (en) * 2018-03-29 2022-01-19 Tata Chemicals Limited Encapsulated micronutrient granules for fortification of edible salt compositions
EP3886603B1 (en) * 2018-11-26 2023-04-19 Purac Biochem B.V. Particulate food preservative composition
WO2020201908A1 (en) * 2019-04-01 2020-10-08 Tata Chemicals Limited Encapsulated micronutrient granules for fortification of edible salt compositions
GB201911105D0 (en) * 2019-08-02 2019-09-18 Governing Council Of The Univ Of Toronto Multi-supplement food-additive
US20220046958A1 (en) * 2020-08-14 2022-02-17 Abt Health And Wellness Private Limited Fortified beverage composition and process of preparing thereof
WO2023196912A2 (en) * 2022-04-06 2023-10-12 Particles For Humanity, Pbc Stabilized vitamin a and method of production
WO2024006539A1 (en) * 2022-07-01 2024-01-04 Vitakey Inc. Nutraceutical particles

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4182778A (en) * 1978-05-17 1980-01-08 General Foods Corporation Encapsulation of vitamin and mineral nutrients
KR920006865B1 (en) 1984-05-18 1992-08-21 워싱톤 유니버시티 테크놀러지 어소우시에이츠 인코오퍼레이티드 Method and apparatus for coating particles or liquid droplets
US4723958A (en) * 1986-05-23 1988-02-09 Merck & Co., Inc. Pulsatile drug delivery system
US5013716A (en) * 1988-10-28 1991-05-07 Warner-Lambert Company Unpleasant taste masking compositions and methods for preparing same
FR2659230A1 (en) 1990-03-08 1991-09-13 Rhone Poulenc Sante PROCESS FOR COATING A ACTIVE SENSITIVE PH POLYMER OF ACTIVE INGREDIENTS.
US5418010A (en) * 1990-10-05 1995-05-23 Griffith Laboratories Worldwide, Inc. Microencapsulation process
JP2893140B2 (en) * 1990-11-30 1999-05-17 エスエス製薬株式会社 Stable vitamin D preparation
US5490962A (en) 1993-10-18 1996-02-13 Massachusetts Institute Of Technology Preparation of medical devices by solid free-form fabrication methods
CA2172509C (en) 1993-10-22 2010-08-24 Jeffrey L. Cleland Methods and compositions for microencapsulation of antigens for use as vaccines
WO1995024929A2 (en) 1994-03-15 1995-09-21 Brown University Research Foundation Polymeric gene delivery system
US5840329A (en) * 1997-05-15 1998-11-24 Bioadvances Llc Pulsatile drug delivery system
EP1064000B1 (en) * 1998-03-27 2011-07-06 Oregon Health & Science University Vitamin d and its analogs in the treatment of tumors and other hyperproliferative disorders
IN191070B (en) * 1998-05-28 2003-09-13 Internat Dev Res Ct
US6740341B1 (en) * 1998-11-25 2004-05-25 Cima Labs Inc. Taste masking rapid release coating system
US6500463B1 (en) * 1999-10-01 2002-12-31 General Mills, Inc. Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles
AU8015300A (en) 1999-10-12 2001-04-23 Ohio State University, The Reactive polymeric valve, dispensing devices and methods using same
US20040033241A1 (en) 2000-06-02 2004-02-19 Allergan, Inc. Controlled release botulinum toxin system
US6887493B2 (en) * 2000-10-25 2005-05-03 Adi Shefer Multi component controlled release system for oral care, food products, nutraceutical, and beverages
CA2437899C (en) 2001-02-13 2012-05-15 Gregory M. Glenn Vaccine for transcutaneous immunization against etec-caused traveler's diarrhea
US7285289B2 (en) 2002-04-12 2007-10-23 Nagy Jon O Nanoparticle vaccines
CA2483028C (en) 2002-05-06 2011-04-05 Massachusetts Institute Of Technology Diffusion-controlled dosage form and method of fabrication including three dimensional printing
US20040234579A1 (en) * 2003-05-22 2004-11-25 Mark D. Finke, Inc. Dietary supplements and methods of preparing and administering dietary supplements
JP2007518669A (en) 2003-12-15 2007-07-12 カウンシル オブ サイエンティフィク アンド インダストリアル リサーチ Flavor masked pharmaceutical composition comprising a pH sensitive polymer
MXPA06007144A (en) 2003-12-24 2007-01-31 Cerus Corp Recombinant nucleic acid molecules encoding fusion proteins comprising antigens and bacterial secretory signal polypeptides, expression cassettes, and bacteria, and methods of use thereof.
US9492400B2 (en) 2004-11-04 2016-11-15 Massachusetts Institute Of Technology Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
DE102005009241A1 (en) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Dosage forms with controlled bioavailability
WO2006097456A1 (en) * 2005-03-16 2006-09-21 Nycomed Gmbh Taste masked dosage form containing roflumilast
US9205047B2 (en) * 2005-04-25 2015-12-08 The Governing Council Of The University Of Toronto Tunable sustained release of a sparingly soluble hydrophobic therapeutic agent from a hydrogel matrix
US9180102B2 (en) 2005-05-06 2015-11-10 Board Of Regents, The University Of Texas System Methods for fabricating nano and microparticles for drug delivery
EA200800092A1 (en) 2005-06-20 2008-06-30 Элан Фарма Интернэшнл Лимитед Compositions in the form of nanoparticles and with controlled release, including aryl-hetero-cyclic compounds
CN103211779B (en) * 2006-01-27 2016-03-16 阿代尔制药股份有限公司 Comprise alkalescence selectivity 5-hydroxy tryptamine 5-HT 3blocker and organic acid drug delivery system
CA2644784A1 (en) * 2006-03-13 2007-09-20 Jinling Chen Formulations of sitaxsentan sodium
WO2007112581A1 (en) * 2006-04-03 2007-10-11 Isa Odidi Controlled release delivery device comprising an organosol coat
US20080031927A1 (en) * 2006-07-11 2008-02-07 Catani Steven J Solid oral dosage vitamin and mineral compositions
US20080026040A1 (en) 2006-07-31 2008-01-31 Isaac Farr Active agent-releasing dosage forms
US20080075785A1 (en) * 2006-09-22 2008-03-27 San-Laung Chow Controlled release hydrogel formulation
ES2692437T3 (en) * 2007-08-13 2018-12-03 Abuse Deterrent Pharmaceutical Llc Abuse-resistant drugs, method of use and method of preparation
CN105770878A (en) 2007-10-12 2016-07-20 麻省理工学院 Vaccine Nanotechnology
US8563066B2 (en) * 2007-12-17 2013-10-22 New World Pharmaceuticals, Llc Sustained release of nutrients in vivo
US20110020519A1 (en) * 2008-01-04 2011-01-27 Aveka, Inc. Encapsulation of oxidatively unstable compounds
JP2011514337A (en) 2008-02-25 2011-05-06 ノババックス，インコーポレイテッド Sugar vitrified virus-like particles (VLP)
AR076835A1 (en) * 2009-05-01 2011-07-13 Eurand Inc COMPOSITIONS OF ORAL DISINTEGRATION TABLETS THAT INCLUDE COMBINATIONS OF DRUGS IN ELEVATED AND REDUCED DOSE. METHOD.
WO2011072208A1 (en) * 2009-12-10 2011-06-16 Monosol Rx, Llc Ph sensitive compounds in taste masking within oral thin film strips
US9795576B2 (en) * 2010-09-27 2017-10-24 Basf Se Protective coatings for acidic active ingredients
WO2012075309A1 (en) 2010-12-01 2012-06-07 Yale University Spin spray layer-by-layer assembly systems and methods
US9045728B2 (en) 2010-12-02 2015-06-02 Oncolytics Biotech Inc. Liquid viral formulations
WO2012168882A1 (en) * 2011-06-07 2012-12-13 SPAI Group Ltd. Compositions and methods for improving stability and extending shelf life of sensitive food additives and food products thereof
US20130323350A1 (en) * 2011-10-17 2013-12-05 Allen Seligson Orally dispersible multi-micronutrient dietary supplement composition and methods of using same
CN103251941A (en) 2012-02-16 2013-08-21 海南大学 Animal viral vaccine pulsatile release system, and preparation method and application thereof
IN2014DN10765A (en) 2012-05-30 2015-09-04 Univ California
ES2436249B1 (en) * 2012-06-25 2014-06-23 Javier Alberto ALONSO-VAQUERO VELASCO Antiparasitic composition for the control and treatment of parasites of different animal species, characterized by combining Moxidectin with vitamins: A, D3, and E
MX2016007786A (en) * 2013-12-16 2017-03-03 Massachusetts Inst Technology Fortified micronutrient salt formulations.

Also Published As

Publication number Publication date
US20170216216A1 (en) 2017-08-03
US20150164816A1 (en) 2015-06-18
SG11201604805XA (en) 2016-07-28
US9649279B2 (en) 2017-05-16
CN106061292A (en) 2016-10-26
EP3082471A1 (en) 2016-10-26
WO2015095185A1 (en) 2015-06-25
US11541017B2 (en) 2023-01-03
MX2016007786A (en) 2017-03-03
ES2647791T3 (en) 2017-12-26
CN106061292B (en) 2020-01-21
US20230372254A1 (en) 2023-11-23
EP3082471B1 (en) 2017-10-04

Similar Documents

Publication Publication Date Title
SG10201808645TA (en) Fortified Micronutrient Salt Formulations
WO2012085671A3 (en) Antioxidants in fish oil powder and tablets
MX2014003748A (en) Tropicalizing agent.
MX2017010321A (en) Pet food feeding system.
WO2015016822A3 (en) Solid dietary compositions for ruminants and methods of making and using the same
WO2013049519A3 (en) Compositions, kits and methods for nutritional supplementation with twelve carbon chain fatty acids and twelve carbon chain acylglycerols
NZ707192A (en) Microalgal flour granules and process for preparation thereof
JP2010275318A5 (en)
MX2014000259A (en) Iron supplement composition.
CN102793184A (en) Compound antioxidant nutrition supplement and processing method thereof
WO2013057400A3 (en) Food product useful as a nutritional supplement or complete meal
MX2014004480A (en) Dietary supplements with rapid buccal dissolution.
GR1007520B (en) Extraction and formation of inclusion complexes of propolis active components with hydroxypropyl-β-cyclodextrin.
MX2019005103A (en) Gamma-polyglutamic acid and zinc compositions.
CN102429021A (en) Health milk
NZ707253A (en) Infant nutrition with lipid globules to increase energy expenditure and metabolic flexibility later in life
MX2019000846A (en) Propyl gallate-containing vitamin preparations.
SI2016838T1 (en) Food supplement
Lee Degradation of properties and loss of nutrients in gelatin soft capsules the manufacturing process
Force et al. Parenteral nutrition intravenous fat emulsions product shortage considerations
Asha et al. Encapsulated β-carotene and its use in nutrient formulations against malnutrition
CN102919527A (en) Animal feed
PH22016000006Y1 (en) Food supplement composition that target mother cells involved in abnormal cell growth
RU2012151044A (en) BIOLOGICALLY ACTIVE ADDITIVE
IN2013MU02025A (en)